These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1320655)

  • 1. [Susceptibility of RD-9H8 cells derived from RD cells to enteroviruses and its application for measuring neutralizing antibodies against coxsackievirus group B].
    Yanagihara T; Matsumoto I; Kawana R
    Kansenshogaku Zasshi; 1992 Apr; 66(4):484-9. PubMed ID: 1320655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neutralizing antibodies to Coxsackie virus group B 1986-1988].
    Kuljić-Kapulica N; Zivanović-Marinković V; Krstić L; Nozić M; Budisin A
    Vojnosanit Pregl; 1990; 47(4):294-6. PubMed ID: 2173272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic prevalence of coxsackievirus group B in Greece.
    Mavrouli MD; Spanakis N; Levidiotou S; Politi C; Alexiou S; Tseliou P; Hatzitaki M; Foundouli K; Tsakris A; Legakis NJ; Routsias JG
    Viral Immunol; 2007; 20(1):11-8. PubMed ID: 17425417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM.
    Morgan-Capner P; McSorley C
    J Hyg (Lond); 1983 Jun; 90(3):333-49. PubMed ID: 6306097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the susceptibility of three human gut tumour-derived differentiated epithelial cell lines, primary monkey kidney cells and human rhabdomyosarcoma cell line to 66-prototype strains of human enteroviruses.
    Patel JR; Daniel J; Mathan VI
    J Virol Methods; 1985 Dec; 12(3-4):209-16. PubMed ID: 3009511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human rhabdomyosarcoma cells for rapid detection of enteroviruses by shell-vial assay.
    Pérez-Ruiz M; Navarro-Marí JM; Palacios Del Valle E; Rosa-Fraile M
    J Med Microbiol; 2003 Sep; 52(Pt 9):789-791. PubMed ID: 12909656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal and neonatal neutralizing antibody titers to selected enteroviruses.
    Hammond GW; Lukes H; Wells B; Thompson L; Low DE; Cheang M
    Pediatr Infect Dis; 1985; 4(1):32-5. PubMed ID: 2982132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies to non-polio enteroviruses in human immune serum globulin.
    Dagan R; Prather SL; Powell KR; Menegus MA
    Pediatr Infect Dis; 1983; 2(6):454-6. PubMed ID: 6318195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells.
    Polacek C; Ekström JO; Lundgren A; Lindberg AM
    Virus Res; 2005 Nov; 113(2):107-15. PubMed ID: 15964091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade.
    Crowell RL; Field AK; Schleif WA; Long WL; Colonno RJ; Mapoles JE; Emini EA
    J Virol; 1986 Feb; 57(2):438-45. PubMed ID: 3003376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus.
    Argo E; Gimenez B; Cash P
    Arch Virol; 1992; 126(1-4):215-29. PubMed ID: 1326261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of the neonatal FC receptor in the uncoating of echoviruses and coxsackievirus A9.].
    Usoltseva PS; Alimov AV; Rezaykin AV; Sergeev AG; Novoselov AV
    Vopr Virusol; 2019; 64(3):132-139. PubMed ID: 31622060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marker of coxsackievirus-B4 infection in saliva of patients with type 1 diabetes.
    Badia-Boungou F; Sane F; Alidjinou EK; Ternois M; Opoko PA; Haddad J; Stukens C; Lefevre C; Gueorguieva I; Hamze M; Ismail M; Weill J; Monabéka HG; Bouenizabila E; Moukassa D; Abena AA; Hober D
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presumptive identification of enteroviruses with RD, HEp-2, and RMK cell lines.
    Johnston SL; Siegel CS
    J Clin Microbiol; 1990 May; 28(5):1049-50. PubMed ID: 2161864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human enteroviruses among apparently healthy nursery school children in Accra.
    Attoh J; Obodai E; Adiku T; Odoom JK
    Pan Afr Med J; 2014; 18():66. PubMed ID: 25400833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3.
    Lindberg AM; Crowell RL; Zell R; Kandolf R; Pettersson U
    Virus Res; 1992 Jul; 24(2):187-96. PubMed ID: 1326828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxsackievirus infection and the development of polymyositis/dermatomyositis.
    Nishikai M
    Rheumatol Int; 1994; 14(2):43-6. PubMed ID: 7824834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects in the central nervous system.
    Gauntt CJ; Gudvangen RJ; Brans YW; Marlin AE
    Pediatrics; 1985 Jul; 76(1):64-8. PubMed ID: 2989763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterovirus strain and type-specific differences in growth kinetics and virus-induced cell destruction in human pancreatic duct epithelial HPDE cells.
    Smura T; Natri O; Ylipaasto P; Hellman M; Al-Hello H; Piemonti L; Roivainen M
    Virus Res; 2015 Dec; 210():188-97. PubMed ID: 26260332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of monoclonal antibodies to coxsackievirus B-3 includes type- and group-specific antibodies.
    Yagi S; Schnurr D; Lin J
    J Clin Microbiol; 1992 Sep; 30(9):2498-501. PubMed ID: 1328290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.